Navigation Links
Cerealus Announces Licensing Agreement for Bio-Based Ceregel™, A Next Generation Strength and Retention System

Sustainable Technology Trailblazer Cerealus Holdings to Commercialize UMaine Commercial Paper-Making Technology, Ceregel™

Waterville, ME (Vocus) April 15, 2010 -- Cerealus Holdings, in collaboration with the University of Maine, is excited to announce their latest bio-based technology, “Ceregel™, A Next Generation Strength + Retention System.” Originally patented by DuPont and later developed by the UMaine Process Development Center, Ceregel™ is a smart process proven technology for paper mills that will enable improved productivity and lower production costs.

Ceregel™ utilizes five patents and involves cooking cationic polyacrylamides with cationic starch to form “super” starch molecules, which have improved retention properties for commercial paper machines. Ceregel™ benefits and validated effects include increased strength, increased retention, and higher press solids. Cerealus has secured exclusive licensing rights for Ceregel™ from the University of Maine and recently initiated a full sales and installation campaign.

"This unique technology is an exciting addition to our technology portfolio, and we have already begun an aggressive commercialization campaign," says Tony Jabar, CEO of Cerealus Holdings. "Our process improvements will provide paper mills with various optimization solutions and should enable mills to save up to $14 per ton.”

Mike Bilodeau, Director of the Process Development Center at the University of Maine, went on to say, “This groundbreaking new low-capital technology gives paper makers a range of options to improve product quality, productivity, and lower manufacturing costs. We believe this technology will soon be considered “best known practice” in the industry, deployed across a wide range of paper grades and manufacturing processes.”

In addition to Ceregel™, Cerealus develops a number of sustainable technologies including Holdout™, a non-toxic, biodegradable replacement for fluorinated compounds; Agricultural Mulch Film; compost bags that are odor, water and grease resistant; biodegradable greenhouse film; construction, household, and general purpose plant-based adhesives; and a plant-based coating binder used to replace oil-based, synthetic binders. For more information, visit Cerealus Holdings or call 207-649-1147.

Cerealus Holdings, LLC
Founded in 2004 by Chemist Tony Jabar, Cerealus Holdings, LLC is headquartered in Waterville, ME. The company develops biodegradable, renewable, plant-based materials to replace synthetic compounds, using cutting-edge science and research to unearth sustainable solutions for current and emerging market opportunities. The non-toxic alternatives we provide address a number of varied markets, from food packaging to paper mills to agricultural crop protection. For more information, visit or call 207-649-1147.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
Related Image:
Cerealus Announces Licensing Agreement for Bio-Based Ceregel™,  A Next Generation Strength and Retention System
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris ... that its business and prospects remain fundamentally strong ... Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation to ... completion following review of the final interim efficacy ... 2 Primary Endpoint in men with heavily pretreated ...
(Date:11/24/2015)... , Nov. 24, 2015  Asia-Pacific (APAC) holds ... organisation (CRO) market. The trend of outsourcing to ... margins but higher volume share for the region ... scale, however, margins in the CRO industry will ... Market ( ), finds that the ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an essential ... bound to proteins, copper is also toxic to cells. With a $1.3 million ... (WPI) will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa ...
(Date:11/24/2015)... ... November 24, 2015 , ... This fall, global software solutions leader SAP and ... to develop and pitch their BIG ideas to improve health and wellness in their ... votes to win the title of SAP's Teen Innovator, an all-expenses paid trip to ...
Breaking Biology Technology:
(Date:10/27/2015)... , Oct. 27, 2015 Synaptics Inc. (NASDAQ: ... announced that Google has adopted the Synaptics ® ... solutions to power its newest flagship smartphones, the Nexus ... --> --> ... to provide strategic collaboration in the joint development of ...
(Date:10/26/2015)... 2015  Delta ID Inc., a company focused on ... PC devices, announced its ActiveIRIS® technology powers the iris ... launched by NTT DOCOMO, INC in Japan ... smartphone to include iris recognition technology, after a very ... in May 2015, world,s first smartphone to have this ...
(Date:10/22/2015)...  Aware, Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter ended September 30, 2015.  --> ... $4.0 million, a decrease of 33% compared to $6.0 million in ... of 2015 was $2.2 million, or $0.10 per diluted share, which ... same period a year ago.  --> ...
Breaking Biology News(10 mins):